Study of Economic Burden and Health Care Resource Utilization by Chronic Obstructive Pulmonary Disease Patients in a Tertiary Care Hospital in Western India
Keywords:
COPD, Economic burden, Hospitalisation, admission rate, loss of workAbstract
Introduction: Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability worldwide and accounts for a huge financial burden on health care resources. This study was done over a one year period to determine the cost burden due to COPD, demographic profile and different treatment protocols.
Methods: This cross sectional study included data from 200 patients diagnosed with COPD. This included the data for emergency visits, hospitalization, daily medications used and the costs incurred by the patients. In addition indirect cost burden for work days lost were also calculated.
Results: The average OPD visits per patient per year were 11.32. Emergency room visits were required for almost 50% of the patients. Average admission rate was 1.45 per patient per year. The mean costs incurred per COPD patient per year was Rs. 5654.16 in government set up and Rs. 35,290.28 for private setup. Average loss of work days per patient was 16.45 days per year.
Conclusions: COPD is a huge economic burden to the society. Major costs incurred are due to recurrent hospital admissions for exacerbations. Early diagnosis and proper treatment can significantly reduce the economic burden of the disease and help in efficient utilization of health care resources.
References
Rennad,SL. COPD: Overview of definitations, epidemiolo-gy and factors influencing its development. Chest 1998; 113: 235S-241S.
Global initiative for chronic obstructive lung disease (GOLD) 2014. Global strategy for diagnosis, management and prevention of COPD. Availale form http://www.gold copd.org.
Susannah Benady. The human and Economic burden of COPD : A leading cause of hospital admission in Canada. Canadian thoracic society 2nd Feb 2010. http//www .respiratory guidelines.ca.
Anthony J Guarascio, Shaunta M. Ray, Christopher K. Finch et al. The clinical and economic burden of Chronic obstruc-tive pulmonary disease in the USA. Clinico economics and outcomes research 2013; 5- 235-45.
Teows, Tanws, Chang W F et al. Economic burden of Chron-ic Obstructive Pulmonary Disease. Respirology 2012 Jan; 17(1): 120-6.
Marc Miravitlles, Cristina Murio, Tina Guerrero et. al. Costs of chronic bronchitis and COPD. A one year follow up study. Chest 2003; 123:784-791.
Halbert, RJ, Natoli, JL,et.al. Global burden of COPD: Sys-tematic review and metaanalysis. EUr Respir. J. 2006;528: 523-532
McKay A J, Mahesh P A, Fordhan G Z, Majeed A. Prevalance of COPD in India, a systematic review. Prim Care Respir J.2012;21(3):313-21.
David M.Mannino, ASonioBuist. Global burden of COPD: Risk factors, prevalence and future trends. Lancet 2007; 370:765-73.
Wilson l, Devine E B, SO k. Direct medical costs of chronic obstructive pulmonary disease. Respir Med. 2000;94(3):204-13.
Vettil S K, Salmia M, Rajia K, Kumar S B. Cost of acute ex-acerbation of COPD in patients attending government hos-pital in Kerala India. Alcaholism 2012;30 ( 30): 55-8.
Fabbri LM, Luppi F, Begni B et al. Complex chronic comor-bidities of COPD. EurRespir J. 2008; 31: 204-12.
Y Chen, SL Home, J.A Dosman. Increased susceptibility to lung dysfunction in female smokers Respir Dis. Vol 143, 1991: 1224-1230.
LundbackB,Lindberg A, Lindstorm M et al. Not 15 but 50% of smokers develop COPD? Report from the obstructive lung disease in Northern Sweden studies. Respir Med 2003; 97: 115-22.
Rennard SI, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet 2006; 367:1216-19
Kruti D. Patel, TarachandLalwani, Kartik Shah: Economic burden in direct cost of chronic obstructive pulmonary dis-ease at a tertiary teaching hospital. A prospective observa-tional cohort study. Indian Journal of Pharmacy practice, Vol 7 Issue 3. July- Sep 2014.
Miravitlles m, Mayordomo C, Arte’s M et al. Treatment of COPD and its exacerbations in general practice. Respir Med. 1999; 93: 173-179.
Hilleman DE, Dewar N, Maleskar M et al. Pharmacoeco-nomic evaluation of COPD. Chest 2000; 118: 1278-85.
Murthy k J R, sastry JG. Economic nurden of chronic ob-structive pulmonary disease. National Commission on mac-roeconomic and health burden of disease in India. 2005;264-71.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
